$POAI
Predictive Oncology Inc.

2020 Q1 Form 10-Q Financial Statement

#000117184320004246 Filed on June 08, 2020

View on sec.gov

Income Statement

Concept 2020 Q1 2019 Q1
Revenue $294.9K $255.2K
YoY Change 15.55% -37.99%
Cost Of Revenue $92.66K $73.72K
YoY Change 25.69% -37.18%
Gross Profit $202.3K $181.5K
YoY Change 11.44% -38.31%
Gross Profit Margin 68.58% 71.12%
Selling, General & Admin $3.093M $2.052M
YoY Change 50.71% 14.49%
% of Gross Profit 1528.97% 1130.52%
Research & Development $129.3K
YoY Change
% of Gross Profit 63.94%
Depreciation & Amortization $206.6K $39.53K
YoY Change 422.64% 117.57%
% of Gross Profit 102.12% 21.77%
Operating Expenses $3.222M $2.337M
YoY Change 37.87% 30.87%
Operating Profit -$3.439M -$2.337M
YoY Change 47.16% 56.69%
Interest Expense $50.00K -$440.0K
YoY Change -111.36%
% of Operating Profit
Other Income/Expense, Net -$840.0K -$520.0K
YoY Change 61.54%
Pretax Income -$4.530M -$3.290M
YoY Change 37.69% 86.93%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$4.529M -$3.293M
YoY Change 37.54% 87.11%
Net Earnings / Revenue -1535.66% -1290.23%
Basic Earnings Per Share
Diluted Earnings Per Share -$926.4K -$2.096M
COMMON SHARES
Basic Shares Outstanding 4.886M 1.573M
Diluted Shares Outstanding 4.886M 1.573M

Balance Sheet

Concept 2020 Q1 2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.060M $1.120M
YoY Change 173.21% -49.78%
Cash & Equivalents $3.056M $1.125M
Short-Term Investments
Other Short-Term Assets $260.0K $270.0K
YoY Change -3.7% 28.57%
Inventory $155.7K $289.0K
Prepaid Expenses
Receivables $269.8K $173.4K
Other Receivables $0.00 $1.800M
Total Short-Term Assets $3.744M $3.654M
YoY Change 2.46% 17.01%
LONG-TERM ASSETS
Property, Plant & Equipment $1.378M $148.7K
YoY Change 826.46% 40.28%
Goodwill $15.69M
YoY Change
Intangibles $3.605M $950.0K
YoY Change 279.5% 721.03%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $21.30M $1.433M
YoY Change 1387.04% -50.19%
TOTAL ASSETS
Total Short-Term Assets $3.744M $3.654M
Total Long-Term Assets $21.30M $1.433M
Total Assets $25.05M $5.087M
YoY Change 392.42% -15.21%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.129M $432.2K
YoY Change 623.86% 131.98%
Accrued Expenses $2.143M $797.6K
YoY Change 168.63% 42.83%
Deferred Revenue $44.13K $20.93K
YoY Change 110.85% -46.14%
Short-Term Debt $0.00 $3.080M
YoY Change -100.0%
Long-Term Debt Due $7.789M
YoY Change
Total Short-Term Liabilities $12.37M $4.762M
YoY Change 159.87% 510.49%
LONG-TERM LIABILITIES
Long-Term Debt $2.120M $0.00
YoY Change
Other Long-Term Liabilities $200.0K $260.0K
YoY Change -23.08%
Total Long-Term Liabilities $2.320M $260.0K
YoY Change 792.31%
TOTAL LIABILITIES
Total Short-Term Liabilities $12.37M $4.762M
Total Long-Term Liabilities $2.320M $260.0K
Total Liabilities $14.69M $5.017M
YoY Change 192.88% 540.24%
SHAREHOLDERS EQUITY
Retained Earnings -$87.03M -$66.40M
YoY Change 31.06% 17.47%
Common Stock $58.53K $173.6K
YoY Change -66.29% 47.07%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $10.36M $70.01K
YoY Change
Total Liabilities & Shareholders Equity $25.05M $5.087M
YoY Change 392.42% -15.21%

Cashflow Statement

Concept 2020 Q1 2019 Q1
OPERATING ACTIVITIES
Net Income -$4.529M -$3.293M
YoY Change 37.54% 87.11%
Depreciation, Depletion And Amortization $206.6K $39.53K
YoY Change 422.64% 117.57%
Cash From Operating Activities -$2.973M -$2.049M
YoY Change 45.12% 20.91%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 -$620.0K
YoY Change -100.0% -410.0%
Cash From Investing Activities -$32.51K -$624.7K
YoY Change -94.8% -528.93%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $3.128M $2.480M
YoY Change 26.14% -16.21%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 5.911M 3.636M
YoY Change 62.57% 20.58%
NET CHANGE
Cash From Operating Activities -2.973M -2.049M
Cash From Investing Activities -32.51K -624.7K
Cash From Financing Activities 5.911M 3.636M
Net Change In Cash 2.905M 962.6K
YoY Change 201.84% -34.37%
FREE CASH FLOW
Cash From Operating Activities -$2.973M -$2.049M
Capital Expenditures
Free Cash Flow -$2.973M -$2.049M
YoY Change 45.12% 18.62%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-14144
CY2019Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
21494
CY2020Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
3745
CY2019Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-2136
CY2020Q1 poai Derivatives Debt Issued
DerivativesDebtIssued
120921
CY2019Q1 poai Derivatives Debt Issued
DerivativesDebtIssued
CY2020Q1 poai Equity Instruments Issued Conversion Of Convertible Debt
EquityInstrumentsIssuedConversionOfConvertibleDebt
-16716
CY2019Q1 poai Equity Instruments Issued Conversion Of Convertible Debt
EquityInstrumentsIssuedConversionOfConvertibleDebt
CY2020Q1 poai Extinguishment Of Convertible Debt
ExtinguishmentOfConvertibleDebt
CY2019Q1 poai Extinguishment Of Convertible Debt
ExtinguishmentOfConvertibleDebt
93827
CY2020Q1 poai Forebearanace Settlement On Bridge Loan
ForebearanaceSettlementOnBridgeLoan
CY2019Q1 poai Forebearanace Settlement On Bridge Loan
ForebearanaceSettlementOnBridgeLoan
503009
CY2020Q1 poai Inducement Shares Issued For Debt Extension
InducementSharesIssuedForDebtExtension
41250
CY2019Q1 poai Inducement Shares Issued For Debt Extension
InducementSharesIssuedForDebtExtension
CY2020Q1 poai Payments For Penalties
PaymentsForPenalties
84898
CY2019Q1 poai Payments For Penalties
PaymentsForPenalties
CY2020Q1 poai Proceeds From Debt And Equity Financing Net
ProceedsFromDebtAndEquityFinancingNet
5910903
CY2020Q1 poai Proceeds From Issuance Of Stock Pursuant To Equity Line
ProceedsFromIssuanceOfStockPursuantToEquityLine
1869899
CY2019Q1 poai Proceeds From Issuance Of Stock Pursuant To Equity Line
ProceedsFromIssuanceOfStockPursuantToEquityLine
CY2020Q1 us-gaap Accounts Receivable Net
AccountsReceivableNet
269777
CY2019Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
297055
CY2020Q1 poai Rounding For Reverse Split
RoundingForReverseSplit
362300
CY2019Q1 poai Rounding For Reverse Split
RoundingForReverseSplit
CY2019Q1 poai Stock Issued During Period Value Forebearance For Bridge Loan
StockIssuedDuringPeriodValueForebearanceForBridgeLoan
158350
CY2020Q1 poai Stock Issued During Period Value Inducement To Convertible Debt
StockIssuedDuringPeriodValueInducementToConvertibleDebt
120000
CY2020Q1 poai Transfer Of Fixed Assets To Inventory
TransferOfFixedAssetsToInventory
CY2019Q1 poai Transfer Of Fixed Assets To Inventory
TransferOfFixedAssetsToInventory
9863
CY2020Q1 poai Waiver Shares Issued For Convertible Debt
WaiverSharesIssuedForConvertibleDebt
103284
CY2019Q1 poai Waiver Shares Issued For Convertible Debt
WaiverSharesIssuedForConvertibleDebt
CY2020Q1 poai Warrants Issued
WarrantsIssued
CY2019Q1 poai Warrants Issued
WarrantsIssued
8665
CY2020Q1 poai Warrants Issued Debt Issuance
WarrantsIssuedDebtIssuance
116951
CY2019Q1 poai Warrants Issued Debt Issuance
WarrantsIssuedDebtIssuance
CY2020Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
3128520
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3155641
CY2020Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
269777
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
297055
CY2020Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2142591
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2371633
CY2020Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
901649
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
771574
CY2020Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
97289097
CY2019Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
93653667
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
263600
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
287838
CY2020Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
287838
CY2019Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
263600
CY2020Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
448026
CY2019Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
468564
CY2020Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
76505
CY2019Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
17644
CY2020Q1 us-gaap Assets
Assets
25048996
CY2020Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
159868
CY2019Q4 us-gaap Assets
Assets
22375510
CY2020Q1 us-gaap Assets Current
AssetsCurrent
3744173
CY2019Q4 us-gaap Assets Current
AssetsCurrent
798264
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3056243
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
150831
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
150831
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
162152
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3056243
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1124730
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2905412
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
962578
CY2020Q1 us-gaap Cash Uninsured Amount
CashUninsuredAmount
2744429
CY2020Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2020Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5852718
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4056652
CY2020Q1 us-gaap Common Stock Value
CommonStockValue
58527
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
40567
CY2020Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-weight: bold;">Credit Risk </div></div> <div style=" font-size: 10pt; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; margin: 0pt 0">Financial instruments which potentially subject the Company to concentrations of credit risk consist principally of cash. The Company places its cash with high credit quality financial institutions and, by policy, generally limits the amount of credit exposure to any <div style="display: inline; font-style: italic; font: inherit;">one</div> financial institution. The Company has a credit risk of <div style="display: inline; font-style: italic; font: inherit;">$2,744,429</div> for cash amounts held in a single institution that are in excess of amounts issued by the Federal Deposit Insurance Corporation.</div></div></div></div></div></div></div></div></div>
CY2020Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
44129
CY2019Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
40384
CY2020Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
44129
CY2019Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
40384
CY2020Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
92657
CY2019Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
73717
CY2020Q1 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
267328
CY2019Q1 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
90000
CY2020Q1 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
6425666
CY2019Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
5146226
CY2020Q1 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
493490
CY2019Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
350426
CY2020Q1 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
493490
CY2019Q4 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
350426
CY2020Q1 us-gaap Depreciation
Depreciation
130075
CY2019Q1 us-gaap Depreciation
Depreciation
21882
CY2020Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
206580
CY2019Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
39526
CY2020Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
27107
CY2019Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
50989
CY2020Q1 us-gaap Derivative Liabilities
DerivativeLiabilities
2814798
CY2020Q1 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
2814798
CY2019Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
50989
CY2020Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.93
CY2019Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.09
CY2020Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
110628
CY2020Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-27107
CY2019Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
19408
CY2020Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
491116
CY2019Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
414611
CY2020Q1 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
2151378
CY2020Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
231151
CY2020Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
159868
CY2020Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
196951
CY2020Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
308201
CY2020Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
3207417
CY2020Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-300000
CY2019Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
CY2020Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2828476
CY2019Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1497945
CY2020Q1 us-gaap Goodwill
Goodwill
15690290
CY2019Q4 us-gaap Goodwill
Goodwill
15690290
CY2019 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
8100000
CY2020Q1 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2020Q1 us-gaap Gross Profit
GrossProfit
202286
CY2019Q1 us-gaap Gross Profit
GrossProfit
181524
CY2020Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
CY2019Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-439637
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2020Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-27121
CY2019Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-13491
CY2020Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-27278
CY2019Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-59159
CY2020Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-34473
CY2019Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
47957
CY2020Q1 us-gaap Increase Decrease In Notes Receivable Current
IncreaseDecreaseInNotesReceivableCurrent
CY2019Q1 us-gaap Increase Decrease In Notes Receivable Current
IncreaseDecreaseInNotesReceivableCurrent
631316
CY2020Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
62248
CY2019Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3273
CY2020Q1 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
4096533
CY2019Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
4064023
CY2020Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
3605417
CY2019Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
3649412
CY2020Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
61805
CY2019Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
91410
CY2020Q1 us-gaap Inventory Net
InventoryNet
155683
CY2019Q4 us-gaap Inventory Net
InventoryNet
190156
CY2020Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
60335
CY2019Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
69821
CY2020Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
33543
CY2019Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
28925
CY2020Q1 us-gaap Liabilities
Liabilities
14693606
CY2019Q4 us-gaap Liabilities
Liabilities
11144192
CY2020Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
25048996
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
22375510
CY2020Q1 us-gaap Liabilities Current
LiabilitiesCurrent
12374425
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
10873928
CY2020Q1 us-gaap Liability For Uncertain Tax Positions Current
LiabilityForUncertainTaxPositionsCurrent
0
CY2020Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
7788706
CY2020Q1 us-gaap Long Term Notes Payable
LongTermNotesPayable
2115000
CY2019Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5910903
CY2019Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3635882
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-32510
CY2019Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-624651
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2972981
CY2019Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2048653
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-4529317
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-3293184
CY2020Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-4529317
CY2019Q1 us-gaap Share Based Compensation
ShareBasedCompensation
263600
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
11231318
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.826
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.798
CY2020Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P10Y
CY2019Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P10Y
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000
CY2020Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
262470
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
160222
CY2020Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
3127818
CY2019Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3293184
CY2020Q1 us-gaap Notes Payable
NotesPayable
5932176
CY2019Q4 us-gaap Notes Payable
NotesPayable
4795800
CY2020Q1 us-gaap Notes Payable Current
NotesPayableCurrent
3817176
CY2019Q4 us-gaap Notes Payable Current
NotesPayableCurrent
4795800
CY2020Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
3
CY2020Q1 us-gaap Open Tax Year
OpenTaxYear
2016 2017 2018 2019
CY2020Q1 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
548753
CY2019Q1 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
466566
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-3439352
CY2019Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-2337203
CY2020Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
427211
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
459481
CY2020Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
204181
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
270264
CY2020Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
631392
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
729745
CY2020Q1 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
1117075
CY2019Q1 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
569776
CY2020Q1 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
1117075
CY2019Q1 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
569776
CY2020Q1 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
27110
CY2019Q1 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
53432
CY2020Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
32510
CY2019Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
3198
CY2020Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000
CY2019Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2479709
CY2020Q1 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
1820000
CY2019Q1 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
1250000
CY2020Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2279373
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2279373
CY2020Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1377724
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1507799
CY2020Q1 us-gaap Repayments Of Debt
RepaymentsOfDebt
821916
CY2019Q1 us-gaap Repayments Of Debt
RepaymentsOfDebt
CY2020Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-87028028
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-82498711
CY2020Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
294943
CY2019Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
255241
CY2020Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
264409
CY2019Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
554216
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
287838
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
53472
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
70005
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
10355390
CY2020Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2020Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-weight: bold;">Accounting Policies and Estimates</div></div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; margin: 0pt 0">The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, and expenses and the disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements during the reporting period. Actual results could materially differ from those estimates.</div></div></div></div></div></div></div></div></div>
CY2020Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
CY2019Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4886328
CY2019Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1573152
CY2020Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
4866328
CY2019Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
1573152
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4886328
CY2019Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1573152

Files In Submission

Name View Source Status
0001171843-20-004246-index-headers.html Edgar Link pending
0001171843-20-004246-index.html Edgar Link pending
0001171843-20-004246.txt Edgar Link pending
0001171843-20-004246-xbrl.zip Edgar Link pending
exh_311.htm Edgar Link pending
exh_312.htm Edgar Link pending
exh_321.htm Edgar Link pending
f10q_060820p.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
poai-20200331.xml Edgar Link completed
poai-20200331.xsd Edgar Link pending
poai-20200331_cal.xml Edgar Link unprocessable
poai-20200331_def.xml Edgar Link unprocessable
poai-20200331_lab.xml Edgar Link unprocessable
poai-20200331_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending